- Home
- OMIC vs PASG Comparison
OMIC vs PASG Comparison
Compare OMIC & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMIC
- PASG
- Stock Information
- Founded
- OMIC 2016
- PASG 2017
- Country
- OMIC United States
- PASG United States
- Employees
- OMIC N/A
- PASG N/A
- Industry
- OMIC Medical/Dental Instruments
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- OMIC Health Care
- PASG Health Care
- Exchange
- OMIC Nasdaq
- PASG Nasdaq
- Market Cap
- OMIC 50.4M
- PASG 42.2M
- IPO Year
- OMIC 2021
- PASG 2020
- Fundamental
- Price
- OMIC $20.01
- PASG $0.52
- Analyst Decision
- OMIC Hold
- PASG Strong Buy
- Analyst Count
- OMIC 2
- PASG 3
- Target Price
- OMIC $10.75
- PASG $8.00
- AVG Volume (30 Days)
- OMIC 7.8K
- PASG 138.4K
- Earning Date
- OMIC 03-17-2025
- PASG 03-03-2025
- Dividend Yield
- OMIC N/A
- PASG N/A
- EPS Growth
- OMIC N/A
- PASG N/A
- EPS
- OMIC N/A
- PASG N/A
- Revenue
- OMIC $2,667,000.00
- PASG N/A
- Revenue This Year
- OMIC $0.82
- PASG N/A
- Revenue Next Year
- OMIC $252.64
- PASG N/A
- P/E Ratio
- OMIC N/A
- PASG N/A
- Revenue Growth
- OMIC 2.77
- PASG N/A
- 52 Week Low
- OMIC $5.34
- PASG $0.45
- 52 Week High
- OMIC $23.41
- PASG $1.79
- Technical
- Relative Strength Index (RSI)
- OMIC 56.74
- PASG 39.73
- Support Level
- OMIC $19.82
- PASG $0.52
- Resistance Level
- OMIC $20.27
- PASG $0.60
- Average True Range (ATR)
- OMIC 0.14
- PASG 0.05
- MACD
- OMIC 0.01
- PASG 0.00
- Stochastic Oscillator
- OMIC 44.68
- PASG 20.37
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.